Synovial hypertrophy, not elsewhere classified, shoulder
ICD-10 M67.21 is a billable code used to indicate a diagnosis of synovial hypertrophy, not elsewhere classified, shoulder.
Synovial hypertrophy refers to the abnormal enlargement of the synovial membrane, which lines the joints and produces synovial fluid. In the shoulder, this condition can lead to increased joint stiffness, pain, and decreased range of motion. It is often associated with inflammatory conditions such as rheumatoid arthritis, osteoarthritis, or tenosynovitis. The hypertrophy can result from chronic irritation or inflammation, leading to the thickening of the synovial lining. Patients may present with symptoms such as shoulder pain, swelling, and difficulty in performing overhead activities. Diagnosis typically involves clinical examination, imaging studies like MRI or ultrasound, and sometimes arthroscopy to assess the extent of synovial changes. Treatment may include corticosteroid injections, physical therapy, or surgical interventions to remove the hypertrophied tissue if conservative measures fail. Understanding the underlying cause of synovial hypertrophy is crucial for effective management and to prevent further joint damage.
Detailed clinical notes, imaging results, and treatment plans must be documented.
Patients presenting with shoulder pain and limited range of motion due to synovial hypertrophy.
Orthopedic surgeons should document the extent of synovial involvement and any surgical interventions performed.
Comprehensive history of joint symptoms, laboratory results, and response to treatments.
Patients with autoimmune conditions presenting with synovial hypertrophy as part of their disease process.
Rheumatologists should focus on the systemic implications of synovial hypertrophy and its management.
Used when performing a corticosteroid injection for symptomatic relief.
Document the indication for the procedure and the patient's response.
Orthopedic specialists should ensure to document the joint involved and the specific substance injected.
Synovial hypertrophy in the shoulder is primarily caused by chronic inflammation, which can result from conditions such as rheumatoid arthritis, osteoarthritis, or repetitive strain injuries.
